Stay updated with breaking news from Current Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
01.05.2024 - LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance. Financial Summary and ...
Third quarter sales of $5.7 billion and diluted EPS of $0.97 Adjusted diluted EPS of $1.10 Electronic Components operating margin of 4.1% ...
Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, will report financial results and provide business updates for the first quarter ended March...
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a
MINNEAPOLIS, May 01, 2024 -- Panbela Therapeutics, Inc. , , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today...